Healthcare Triangle, INC 8-K filings

Healthcare Triangle, Inc. has issued over 12.5 million shares of common stock in connection with two M&A transactions, bolstering its market value and compliance with Nasdaq listing standards.

Healthcare Triangle, Inc. shareholders approved key proposals at the annual meeting, including director elections, auditor ratification, stock incentive plan amendments, and various share issuances.

Healthcare Triangle, Inc. enters into a securities exchange agreement to settle debt and amends a share purchase agreement for Teyame AI.

Healthcare Triangle, Inc. has closed a private placement of $4.235 million in senior convertible promissory notes, raising approximately $3.6 million in gross proceeds.

Healthcare Triangle, Inc. has entered into a material definitive agreement with SecureKloud Technologies Limited and its subsidiary Blockedge Technologies Inc. for the development of an integrated health advisory and care platform.

Healthcare Triangle, Inc. filed an amendment to its Form 8-K, providing the necessary financial statements for its recently acquired subsidiaries, Teyam 360 S.L. and Datono Mediacin S.L.

Healthcare Triangle, Inc. announced a registered direct offering of common stock and pre-funded warrants, raising approximately $3.95 million for working capital.

Healthcare Triangle, Inc. completed a 1-for-60 reverse stock split to meet Nasdaq's minimum bid price requirement and maintain its listing.

Healthcare Triangle, Inc. shareholders approved an amendment to its Certificate of Incorporation to effect a reverse stock split at its Special Stockholders Meeting on February 2, 2026.

Healthcare Triangle, Inc. has acquired Teyame AI LLC for up to $50 million, expanding its AI-powered customer experience solutions and global SaaS footprint.

Healthcare Triangle, Inc. has signed an advance agreement to acquire Teyame AI LLC's Spanish subsidiaries for up to $50 million, aiming to boost its AI-powered healthcare and patient engagement solutions.

Healthcare Triangle, Inc. shareholders approved a proposal allowing the company to issue up to $70 million in securities over the next three months, adhering to Nasdaq listing rules.

Healthcare Triangle, Inc. has entered into an agreement to issue up to $15 million in senior unsecured convertible promissory notes, with an initial tranche of $7.5 million principal amount funded at a 20% original issue discount.

Healthcare Triangle, Inc. has established an at-the-market equity offering program to sell up to $20 million of its common stock through Spartan Capital Securities, LLC.

Healthcare Triangle, Inc. shareholders elected four directors and ratified SRCO Professional Corporation as its independent auditor for 2025 at the annual meeting on November 7, 2025.

Healthcare Triangle, Inc. secured approximately $2.85 million in gross proceeds by inducing existing warrant holders to exercise their warrants at a reduced price, issuing new warrants as consideration.

Healthcare Triangle, Inc. announced it has regained compliance with Nasdaq listing rules after amending an acquisition agreement to require shareholder approval for a significant stock issuance, while also outlining a strong 2025 revenue outlook.

Healthcare Triangle, Inc. filed an amendment to its asset transfer agreement with Niyama Healthcare, Inc., adjusting the share consideration for the acquisition and including pro forma financial statements.

Healthcare Triangle, Inc. has completed a 1-for-249 reverse stock split to meet Nasdaq's minimum bid price requirement, effective August 1, 2025.

Healthcare Triangle, Inc. has been granted continued listing on The Nasdaq Capital Market by the Nasdaq Hearings Panel, contingent on a reverse stock split and achieving a minimum bid price of $1.00 per share by September 5, 2025.

Healthcare Triangle, Inc. (HCTI) has successfully completed the acquisition of Niyama Healthcare, Inc.'s mental health SaaS platform and a 100% equity stake in Ezovion Solutions Private Limited, significantly enhancing its digital healthcare offerings and global presence.

Healthcare Triangle, Inc. has received multiple delisting notices from Nasdaq due to its stock trading below $0.10 for ten consecutive days and concerns over substantial shareholder dilution from a recent private placement.

Healthcare Triangle, Inc. has received a formal notification from Nasdaq regarding potential delisting due to substantial shareholder dilution concerns stemming from its recent private placement warrants.

Healthcare Triangle, Inc. has dismissed M&K CPAS, PLLC and engaged SRCO Professional Corporation as its new independent registered public accounting firm, effective April 11, 2025.

Healthcare Triangle, Inc. announces the appointment of David Ayanoglou as Chief Financial Officer and Sujatha Ramesh as a Director on the Board.

Healthcare Triangle, Inc. held its annual shareholder meeting on March 28, 2025, where shareholders elected directors, approved an amendment to the 2020 stock incentive plan, and ratified the appointment of M&K CPAS, PLLC as the company's independent auditor.

Healthcare Triangle, Inc. has appointed Sujatha Ramesh as its new Chief Operating Officer, effective immediately.

Healthcare Triangle, Inc. announces a $15.2 million private placement to strengthen its balance sheet and support general corporate activities.

Healthcare Triangle, Inc. receives notice from Nasdaq regarding non-compliance with minimum bid price rule and is working to regain compliance, while also addressing stockholders' equity and annual meeting requirements.

Healthcare Triangle, Inc. will restate its 2023 financial statements due to errors identified during a re-audit, primarily related to intangible assets and the application of accounting standards.